<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-142866</identifier>
<setSpec>1576-9895</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">No disponible</dc:title>
<dc:description xml:lang="en">Existence of endotracheal metastases (EM) of non-pulmonary origin cancer is rare. The most common clinical manifestations are hemoptysis, cough and dyspnea, although it is not rare to find it as a casual finding during a bronchoscope examination. The neoplasms that are most frequently associated to these lesions are those derived from the breast, colon and kidney. When they are found, it means that there is an advanced stage of the disease, although survival is based on the type of primary tumor, existence of common commitment lesions and the characteristics of the patient. Thus, the treatment should be individualized. In the case of colorectal carcinoma (CRC) EM, we recommend performing a pre-operative bronchoscopy since lesions that influence the prognoses and treatment of the disease may be found in the trachea and bronchial tree (AU)</dc:description>
<dc:creator>Naval Sendra, E</dc:creator>
<dc:creator>Sales Badía, JG</dc:creator>
<dc:creator>Navarro Hervás, M</dc:creator>
<dc:creator>Cordero Rodríguez, P</dc:creator>
<dc:creator>Galbis Caravajal, JM</dc:creator>
<dc:creator>Jordá Aragón, C</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La existencia de metástasis endotraqueales (ME) de carcinomas de origen no pulmonar es rara. Las manifestaciones clínicas más comunes son hemoptisis, tos y disnea, aunque no es raro encontrarlas como hallazgo casual en el curso de una broncoscopia. Las neoplasias que con mayor frecuencia se asocian a estas lesiones metastásicas son las derivadas de mama, colon y riñón. Su hallazgo supone un estado avanzado de la enfermedad, aunque la supervivencia está en función del tipo de tumor primario, la existencia de lesiones concomitantes y las características del paciente. Por lo tanto el tratamiento debe individualizarse. En el caso de las ME de carcinoma colorrectal (CCR) recomendamos la realización de una broncoscopia preopcratoria pues es posible encontrar lesiones en el árbol traqueobronquial que influyan en el pronóstico y tratamiento de la enfermedad (AU)</dc:description>
<dc:source>Rev. patol. respir;11(4): 179-181, oct.-nov. 2008. ilus</dc:source>
<dc:identifier>ibc-142866</dc:identifier>
<dc:title xml:lang="es">Metástasis endotraqueales de carcinoma colorrectal</dc:title>
<dc:subject>^d23595^s22053</dc:subject>
<dc:subject>^d22703^s22064</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d2026^s22074</dc:subject>
<dc:subject>^d9555^s22053</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:type>article</dc:type>
<dc:date>200811</dc:date>
</metadata>
</record>
</ibecs-document>
